A Study of Human Monoclonal Antibodies, BRII-196 and BRII-198
Clinical trial NCT04787211 · COMPLETED
Trial details
- NCT number
- NCT04787211
- Sponsor
- Brii Biosciences Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-20
- Primary completion
- 2021-12-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.